Dr. Kefeng Ding: Exploration of the Balance between Radical Resection and Functional Preservation in Colorectal Cancer Treatment with LISH Procedure| Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

Dr. Kefeng Ding: Exploration of the Balance between Radical Resection and Functional Preservation in Colorectal Cancer Treatment with LISH Procedure| Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

2025.03.21
At the 9th Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee, Dr. Kefeng Ding from The Second Affiliated Hospital  Zhejiang University School of Medicine presented innovative advancements in laparoscopic ileocecal-sparing hemicolectomy (LISH) for right-sided colon cancer, highlighting its potential to balance oncologic radicality with functional preservation. His insights provide valuable guidance for clinical practice, promoting precision surgery and organ function preservation in colorectal cancer treatment. Oncology Frontier presents key highlights from his lecture.
Dr. Xiujuan Qu: Breakthroughs in Precision Treatment for Advanced Colorectal Cancer – KRAS G12C Inhibitors Leading the Way

Dr. Xiujuan Qu: Breakthroughs in Precision Treatment for Advanced Colorectal Cancer – KRAS G12C Inhibitors Leading the Way

2025.03.21
With the discovery of molecular targets and the development of corresponding targeted inhibitors, the treatment of metastatic colorectal cancer (mCRC) is becoming increasingly precise and personalized. At the recent 9th Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee, Dr. Xiujuan Qu from The First Hospital of China Medical University shared the latest advancements in precision treatment for advanced colorectal cancer, including novel therapeutic strategies and the promising role of KRAS G12C inhibitors.
SGBCC 2025 | Dr. Cynthia Villarreal-Garza: Monitoring and Management of Long-term Toxicities in Young Breast Cancer Patients

SGBCC 2025 | Dr. Cynthia Villarreal-Garza: Monitoring and Management of Long-term Toxicities in Young Breast Cancer Patients

2025.03.20
The impact of long-term toxicity management on patient quality of life is increasingly being recognized in breast cancer treatment. At the recently held 19th St. Gallen Breast Cancer Conference (SGBCC 2025), Dr. Cynthia Villarreal-Garza, Director of Clinic Oncology at the Breast Cancer Center, TecSalud,delivered a presentation titled “Ensuring Long-term Healthy Survival of Breast Cancer Patients.” She pointed out that young breast cancer patients, due to the high intensity and long duration of their treatment, face a number of unique toxicity issues that not only affect their physical health but also have a profound impact on their psychological well-being, social functioning, and overall quality of life. To monitor and intervene in these long-term toxicities, Professor Villarreal-Garza proposed the application of “evidence-based approaches for healthy living” and the use of remote monitoring applications to effectively manage toxicities and improve patient quality of life.